 |
 |
Chris van der Linden wrote: > > Call Roche, the makers of Madopar and Prolopa in Europe and ask them to > register these drugs in the USA. It is still not clear to me why this has > not happened. Do the two companies have some sort of an agreement, > bypassing anti-trust laws or am I too paranoia? > I'm unaware of any advantage of Madopar or Prolopa (don't know that one) over Sinemet, either medical or cost. Could you explain a bit please? I'm pretty sure that Sinemet has outlived its patent protection, and that might discourage introduction of a competitive product. Cheers, Joe -- J. R. Bruman (818) 789-3694 3527 Cody Road Sherman Oaks, CA 91403-5013